Literature DB >> 18343279

Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden.

Syed Imran Haider1, Kristina Johnell, Mats Thorslund, Johan Fastbom.   

Abstract

BACKGROUND: Polypharmacy is an important patient safety concern and has been associated with increased adverse drug reactions, hospitalization, and mortality in the elderly. However, few studies have analyzed the association between socioeconomic position (SEP) and the extent of drug use in older people.
OBJECTIVES: The aims of this study were to investigate the prevalence of polypharmacy and the association between polypharmacy and SEP, as measured by education, occupation, and income.
METHODS: For this cross-sectional study, data from a nationally representative sample (Swedish Panel Study of Living Conditions of the Oldest Old [SWEOLD] 2002) aged > or =77 years were analyzed (n = 621). Information on drug use was based on personal interviews, and polypharmacy was defined as concurrent use of > or =5 drugs. Other measurements included were age, sex, education, occupation, income, comorbidity, marital status, and living situation. The association between polypharmacy and SEP was assessed by logistic regression.
RESULTS: The mean number of drugs used in the sample was 4.4; in less educated patients, 4.6; more educated, 4.0. Polypharmacy was observed in 42.2% of the elderly. Overall, antithrombotic agents (42.5%), P-blocking agents (28.3%), and high-ceiling diuretics (28.0%) were the most prevalent drugs. Low education was associated with polypharmacy (odd ratio [OR], 1.46; 95% CI, 1.02-2.07), after controlling for age and sex. However, the association between low education level and polypharmacy was not significant after adjustment for age, sex, comorbidity, marital status, and living situation (OR, 1.39; 95% CI, 0.95-2.04). Moreover, we did not observe any association between occupation or income and polypharmacy.
CONCLUSIONS: The results from this study suggest that >40% of people aged > or =77 years in Sweden are exposed to polypharmacy, defined as the use of > or =5 drugs. There was a higher prevalence of polypharmacy among elderly with low education. However, after controlling for comorbidity, martial status, and living situation, polypharmacy was not related to low education. Further studies in larger populations are needed to elucidate the association between SEP and drug use.

Entities:  

Mesh:

Year:  2008        PMID: 18343279     DOI: 10.1016/j.clinthera.2008.02.010

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  37 in total

1.  Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors.

Authors:  E Pappa; N Kontodimopoulos; A A Papadopoulos; Y Tountas; D Niakas
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

2.  Characteristics of polymedicated (≥ 4) elderly: a survey in a community-dwelling population aged 60 years and over.

Authors:  N Husson; G Watfa; M-C Laurain; C Perret-Guillaume; J-Y Niemier; P Miget; A Benetos
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

3.  Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients.

Authors:  Christoph Strehblow; Michael Smeikal; Peter Fasching
Journal:  Wien Klin Wochenschr       Date:  2014-01-21       Impact factor: 1.704

4.  Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy.

Authors:  S Lane Slabaugh; Vittorio Maio; Megan Templin; Safiya Abouzaid
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

5.  Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.

Authors:  Johanna Jyrkkä; Hannes Enlund; Maarit J Korhonen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Polypharmacy and Depressive Symptoms in U.S.-Born Mexican American Older Adults.

Authors:  Shervin Assari; Cheryl Wisseh; Mohammed Saqib; Hamid Helmi; Mohsen Bazargan
Journal:  Psych       Date:  2019-11-01

7.  Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people.

Authors:  Syed Imran Haider; Kristina Johnell; Gunilla Ringbäck Weitoft; Mats Thorslund; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2008-08-10       Impact factor: 2.953

8.  Polypharmacy status as an indicator of mortality in an elderly population.

Authors:  Johanna Jyrkkä; Hannes Enlund; Maarit J Korhonen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Social Determinants of Polypharmacy in First Generation Mexican Immigrants in the United States.

Authors:  Shervin Assari; Mohammed Saqib; Cheryl Wisseh; Mohsen Bazargan
Journal:  Int J Travel Med Glob Health       Date:  2019

10.  Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.

Authors:  Bo Hovstadius; Bengt Astrand; Göran Petersson
Journal:  BMC Clin Pharmacol       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.